Emerging Markets

In this report, we gather these responses as well as expert insight on the findings along with interviews with thought leaders and articles on key trends to give you an in depth look at the current st...

Ahead of the 10th anniversary for IQPC’s International Conference Intelligent Compound Libraries, Dr Thomas Maier - Head of Library Production & Purification at Sanofi-Aventis discusses th...

Globally innovation is shifting to emerging markets. Find out more in this latest infographic on geographic shifts in innovation. By JLL -2014 Global Life Sciences Cluster Report...

Clinical trial supply is a complicated enough business, but working internationally can really complicate matters. Lindsay Pinnick, Clinical Supply Manager at UCB, speaks to Pharma IQ abou...

Clinical trial supply is a complicated enough business, but working internationally can really complicate matters. Lindsay Pinnick, Clinical Supply Manager at UCB, speaks to Pharma IQ abou...

The latest results from Pharma IQ’s survey of industry  professionals highlights that running clinical trials in emerging market (e.g. BRIC) nations remains a firm priority for compa...

To better understand both the challenges faced by the global pharmaceutical industry in its pursuit of emerging-market opportunities and the strategies that leaders are employing to address them, Bo...

One in every two top pharma company managers expects share of revenues coming from emerging markets to exceed 30% by 2018 Local idiosyncrasies make it essential to have bespoke approaches...

Against of backdrop of unsuccessful new drug discovery, patent expiry and a particularly tough global economic economy, the pharmaceutical industry model has had to change and over the last 10 years...

---For immediate release--- In the wake of high profile staff cuts at multinational global pharmaceutical and biotech companies, leading industry network Pharma IQ conducted a large scale study in...

Facing an estimated loss of $14.7 billion in revenue through 2013 as a number patents for blockbuster drugs are set to expire, pharmaceutical and biotechnology companies are seeking ways to increase...